ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02426229
Brief Title: Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma

First Submitted : March 4, 2015
First Submitted that Met QC Criteria : April 23, 2015
First Posted : April 24, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : July 12, 2018
Last Update Posted : July 13, 2018